NASDAQ
Cyclerion Therapeutics, Inc. (CYCN) has a current ratio of 5.15x as of Monday, May 25, 2026. This represents a 23.95% increase compared to its 12-month average of 4.16x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.